Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications

The impaired ability to mount an effective immune response to vaccination leaves immunosuppressed patients at higher risk of severe COVID-19 infection. This retrospective study aimed to evaluate COVID-19 seroconversion and antibody titers for patients on immune modulating therapies compared to those...

Descripción completa

Detalles Bibliográficos
Autores principales: Levit, Elle, Longbrake, Erin E., Stoll, Sharon S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890787/
https://www.ncbi.nlm.nih.gov/pubmed/35276450
http://dx.doi.org/10.1016/j.msard.2022.103719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890787/
https://www.ncbi.nlm.nih.gov/pubmed/35276450
http://dx.doi.org/10.1016/j.msard.2022.103719

Ejemplares similares